PCA
ZBH icon

Pallas Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Pallas Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,992
Closed -$295K – 968
2025
Q3 		$295K Sell
2,992
-369
-11% -$36.6K 0.01% 674
2025
Q2 		$307K Buy
+3,361
New +$325K 0.01% 644

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Pallas Capital Advisors's ZBH Position: Q4 2025 in Review

Pallas Capital Advisors sold out of Zimmer Biomet (ZBH) in Q4 2025, closing a stake of 2,992 shares — an estimated $295K sold.

Pallas Capital Advisors first reported a position in ZBH in Q2 2025 and held it in 2 quarters. The position peaked at $307K in Q2 2025. 946 funds tracked by Wall St. Rank hold ZBH as of Q4 2025.

  • Pallas Capital Advisors reported no remaining Zimmer Biomet position as of Q4 2025 after selling out during the quarter.
  • Pallas Capital Advisors sold 2,992 Zimmer Biomet shares in Q4 2025, an estimated $295K.
  • Pallas Capital Advisors first reported a position in Zimmer Biomet in Q2 2025 and held it in 2 quarters.
  • Pallas Capital Advisors's Zimmer Biomet position peaked at $307K in Q2 2025.
  • 946 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2025.

Based on Pallas Capital Advisors's 13F filing for Q4 2025, filed 14 Jan 2026.